Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015721
Filing Date
2024-11-14
Accepted
2024-11-14 16:19:55
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scpx-20240930x10q.htm   iXBRL 10-Q 1993785
2 EX-31.1 scpx-20240930xex31d1.htm EX-31.1 27053
3 EX-31.2 scpx-20240930xex31d2.htm EX-31.2 27367
4 EX-32.1 scpx-20240930xex32d1.htm EX-32.1 12529
5 EX-32.2 scpx-20240930xex32d2.htm EX-32.2 13611
  Complete submission text file 0001558370-24-015721.txt   10065420

Data Files

Seq Description Document Type Size
6 EX-101.SCH scpx-20240930.xsd EX-101.SCH 78854
7 EX-101.CAL scpx-20240930_cal.xml EX-101.CAL 92785
8 EX-101.DEF scpx-20240930_def.xml EX-101.DEF 277296
9 EX-101.LAB scpx-20240930_lab.xml EX-101.LAB 716375
10 EX-101.PRE scpx-20240930_pre.xml EX-101.PRE 512023
83 EXTRACTED XBRL INSTANCE DOCUMENT scpx-20240930x10q_htm.xml XML 1770489
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 241462742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)